Finance

Lists
Why is ADMA up 3.32%?
Dive Deeper
ADMA:NASDAQ
ADMA Biologics Inc
$13.68
+3.32%
(+0.44) 1D
$13.65
-0.22% (-0.030)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADMA...
Open
$13.29
High
$14.02
Low
$13.07
Mkt. cap
3.03B
Avg. vol.
3.69M
Volume
4.16M
P/E ratio
17.60
52-wk high
$20.46
52-wk low
$7.21
EPS
$0.78
Beta
0.65
Shares outstanding
221.85M
No. of employees
644
Open
$13.29
High
$14.02
Low
$13.07
Mkt. cap
3.03B
Avg. vol.
3.69M
Volume
4.16M
P/E ratio
17.60
52-wk high
$20.46
52-wk low
$7.21
EPS
$0.78
Beta
0.65
Shares outstanding
221.85M
No. of employees
644
News stories
From web sources and news partners
About ADMA Biologics Inc
CEO-
Employees644
Founded2004
HeadquartersRamsey, New Jersey, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to ADMA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ADMA in the last 3 months.
Highest
Current $13.68
$19.00 (+38.89%)
Average
$16.67 (+21.86%)
Lowest
$13.00 (-4.97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Petrone
Mizuho Securities
Buy
Maintained
$18.00
+31.6%
11/05/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
$13.00
-5%
11/05/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
$19.00
+38.9%
11/05/2026
Ryan Deschner
Raymond James
Buy
Initiated
$21.00
+53.5%
06/10/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
$21.00
+53.5%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
139.16M
114.49M
124.40M
141.10M
Cost of goods sold
50.35M
33.74M
38.12M
41.18M
Cost of revenue
50.35M
33.74M
38.12M
41.18M
Research and development expenses
1.38M
2.60M
6.01M
4.49M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.64M
27.80M
27.76M
27.61M
Operating expense
26.06M
30.46M
33.83M
32.16M
Total operating expenses
76.41M
64.20M
71.95M
73.34M
Operating income
62.75M
50.29M
52.44M
67.76M
Other non operating income
-17.00K
-140.00K
-22.00K
-19.00K
EBT including unusual items
61.60M
57.13M
50.24M
65.60M
EBT excluding unusual items
61.60M
49.15M
50.24M
65.60M
Income tax expense
12.22M
11.80M
12.42M
15.72M
Effective tax rate
19.83%
20.65%
24.71%
23.96%
Other operating expenses
-
-
-
-
Net income
49.38M
45.33M
37.82M
49.88M
Net profit margin
35.48%
39.59%
30.40%
35.35%
Earnings per share
0.22
0.17
0.17
0.23
Interest and investment income
487.00K
1.09M
1.24M
1.30M
Interest expense
-1.63M
-2.10M
-3.42M
-3.43M
Net interest expenses
-1.14M
-1.01M
-2.19M
-2.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
64.80M
52.13M
54.23M
69.55M
Gain or loss from assets sale
9.00K
-7.94M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps